Institutional members access full text with Ovid®

Share this article on:

Spectral Ripple Discrimination in Normal-Hearing Infants

Horn, David L. MD, MS; Won, Jong Ho PhD; Rubinstein, Jay T. MD, PhD; Werner, Lynne A. PhD

doi: 10.1097/AUD.0000000000000373
Research Articles

Objectives: Spectral resolution is a correlate of open-set speech understanding in postlingually deaf adults and prelingually deaf children who use cochlear implants (CIs). To apply measures of spectral resolution to assess device efficacy in younger CI users, it is necessary to understand how spectral resolution develops in normal-hearing children. In this study, spectral ripple discrimination (SRD) was used to measure listeners’ sensitivity to a shift in phase of the spectral envelope of a broadband noise. Both resolution of peak to peak location (frequency resolution) and peak to trough intensity (across-channel intensity resolution) are required for SRD.

Design: SRD was measured as the highest ripple density (in ripples per octave) for which a listener could discriminate a 90° shift in phase of the sinusoidally-modulated amplitude spectrum. A 2 × 3 between-subjects design was used to assess the effects of age (7-month-old infants versus adults) and ripple peak/trough “depth” (10, 13, and 20 dB) on SRD in normal-hearing listeners (experiment 1). In experiment 2, SRD thresholds in the same age groups were compared using a task in which ripple starting phases were randomized across trials to obscure within-channel intensity cues. In experiment 3, the randomized starting phase method was used to measure SRD as a function of age (3-month-old infants, 7-month-old infants, and young adults) and ripple depth (10 and 20 dB in repeated measures design).

Results: In experiment 1, there was a significant interaction between age and ripple depth. The infant SRDs were significantly poorer than the adult SRDs at 10 and 13 dB ripple depths but adult-like at 20 dB depth. This result is consistent with immature across-channel intensity resolution. In contrast, the trajectory of SRD as a function of depth was steeper for infants than adults suggesting that frequency resolution was better in infants than adults. However, in experiment 2 infant performance was significantly poorer than adults at 20 dB depth suggesting that variability of infants’ use of within-channel intensity cues, rather than better frequency resolution, explained the results of experiment 1. In experiment 3, age effects were seen with both groups of infants showing poorer SRD than adults but, unlike experiment 1, no significant interaction between age and depth was seen.

Conclusions: Measurement of SRD thresholds in individual 3 to 7-month-old infants is feasible. Performance of normal-hearing infants on SRD may be limited by across-channel intensity resolution despite mature frequency resolution. These findings have significant implications for design and stimulus choice for applying SRD for testing infants with CIs. The high degree of variability in infant SRD can be somewhat reduced by obscuring within-channel cues.

1Virginia Merrill Bloedel Hearing Research Center, Department of Otolaryngology-Head and Neck Surgery, University of Washington, Seattle, Washington, USA; 2Division of Otolaryngology, Seattle Children’s Hospital, Seattle, Wahington, USA; and 3Department of Speech and Hearing Sciences, University of Washington, Seattle, Washington.

This research was funded by the American Otological Society (Clinician-Scientist Award), and the National Institutes of Health (NIDCD R01DC00396, K23DC013055, and P30DC04661).

Dr. Rubinstein has served as a consultant to and/or has previously received research funding from Cochlear, Ltd, Advanced Bionics Corp, and Oticon Medical, manufactorers of cochlear implants. There are no other conflicts of interest to disclose.

Received January 27, 2016; accepted August 13, 2016.

Address for correspondence: David L. Horn, MD, MS, Department of Otolaryngology-Head and Neck Surgery, University of Washington, CHDD Building, CD176, Box#357923, Seattle, WA 98195, USA. E-mail:

Copyright © 2017 Wolters Kluwer Health, Inc. All rights reserved.